AbbVie Raises 2025 Outlook Helped By Strong Immunology Growth, Boost Dividend

benzinga.com/markets/earnings/25/10/48564942/abbvie-raises-2025-outlook-helped-by-strong-immunology-growth-boost-dividend

AbbVie Inc. (NYSE:ABBV) reported third-quarter 2025 sales of $15.78 billion on Friday, beating the consensus of $15.59 billion.
Sales increased 9.1% on a reported basis or 8.4% on an operational basis. The company reported adjusted earnings of $1.86 per share, down 38%, beating the…

This story appeared on benzinga.com, 2025-10-31 15:47:20.
The Entire Business World on a Single Page. Free to Use →